Pharma Likelihood Of Approval
We are the trusted, gold standard intelligence provider to the world’s largest industries
GlobalData powers faster, more informed decisions with:
- Granular industry intelligence: We develop deep, vertical-specific intelligence tailored to your industry, providing 360° insight.
- Exhaustive coverage: We synthesize our vast data universe into formats that support your decision-making needs, covering the sectors, themes, companies and geographies that matter to you.
- Proprietary datasets: We provide you with access to untapped pools of intelligence generated from our proprietary datasets and primary research capabilities.
- Robust methodologies: The quality and timeliness of our data is a key differentiator. We leverage robust research methodologies to turn millions of data points into trusted intelligence.
Thousands of companies, government organizations, and decision makers rely on GlobalData
We have a track record of serving truly diverse clients, including:
- Corporates: From helping the C-suite refine strategy to powering innovation in marketing and R&D, our corporate use cases are endless.
- Investment firms: We help financial analysts develop robust long-term strategies and get alpha signals before the rest.
- Professional services: We give consultants, legal, and accounting firms the critical insights to make faster, more informed decisions.
- Other sectors: From media to academia, we work with sectors as diverse as our data.
The trusted, actionable and future-proof insight you need to stay ahead
We have decades of experience in being the gold standard intelligence provider based on:
- Unique data: Proprietary datasets built from terabytes of data. Our unmatched intelligence gives you true strategic advantage.
- Expert analysis: Leverage collective expertise. Count on our extensive team of researchers, analysts, subject matter experts, and journalists, plus thousands of external thought-leaders.
- Real intelligence over AI: Experience a level of analysis that leaves AI in the dust. Unlock the proprietary datasets unseen by AI and gain a decisive edge.
- Time-saving research solutions: Save hundreds of hours on research. Our comprehensive reports let you focus on delivering actionable insights - not searching for them.
- Unparalleled global coverage: Tap into insights from anywhere. Our extensive global coverage offers an unrivalled view of the market landscape.
- One platform: Access all our unique data, expert analysis, and innovative solutions on one platform.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Talimogene Laherparepvec in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Talimogene Laherparepvec in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Talimogene Laherparepvec in Pancreatic Ductal Adenocarcinoma Drug Details: Talimogene laherparepvec...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Ruxolitinib Phosphate in Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ruxolitinib Phosphate in Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ruxolitinib Phosphate in Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Ruxolitinib Phosphate in Bronchiolitis Obliterans
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ruxolitinib Phosphate in Bronchiolitis Obliterans report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ruxolitinib Phosphate in Bronchiolitis Obliterans Drug Details: Ruxolitinib (INCB18424, Jakafi, Jakavi)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Ruxolitinib Phosphate in Breast Hyperplasia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ruxolitinib Phosphate in Breast Hyperplasia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ruxolitinib Phosphate in Breast Hyperplasia Drug Details: Ruxolitinib (INCB18424, Jakafi, Jakavi)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Valiltramiprosate in Down Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Valiltramiprosate in Down Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Valiltramiprosate in Down SyndromeDrug Details:ALZ-801 is under development for the treatment of Alzheimer’s...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Alferminogene Tadenovec in Myocardial Ischemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Alferminogene Tadenovec in Myocardial Ischemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Alferminogene Tadenovec in Myocardial IschemiaDrug Details:Alferminogene tadenovec (Generx) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Anakinra in Myocarditis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anakinra in Myocarditis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anakinra in Myocarditis Drug Details: Anakinra (Kineret) is an immunosuppressant produced in Escherichia...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - CBL-0137 in Pediatric Diffuse Intrinsic Pontine Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CBL-0137 in Pediatric Diffuse Intrinsic Pontine Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CBL-0137 in Pediatric Diffuse Intrinsic Pontine GliomaDrug Details:CBL-0137 (CBLC-137) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Endostatin in Nasopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Endostatin in Nasopharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Endostatin in Nasopharyngeal CancerDrug Details: Endostatin (Endostar/ Recombinant Human Endostatin) is a angiostatic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - VK-5211 in Bone Fracture
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VK-5211 in Bone Fracture report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.VK-5211 in Bone FractureDrug Details:VK-5211 (LGD-4033) is under development for the treatment of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.